In a recent interview with Iyaku Keizai, Jahoon Kang, Vice President and Head of CDO Sales Execution at Samsung Biologics, shared how our integrated CDMO services are enabling pharma companies to streamline development and manufacturing.
Key highlights include:
- Strategies to accelerate technology transfer and market entry
- Ongoing investment in drug product capabilities, including pre-filled syringes
- Flexible infrastructure and advanced technologies that support stable, high-quality production across diverse modalities
In a recent interview with Iyaku Keizai, Jahoon Kang, Vice President and Head of CDO Sales Execution at Samsung Biologics, shared how our integrated CDMO services are enabling pharma companies to streamline development and manufacturing.
Key highlights include:
- Strategies to accelerate technology transfer and market entry
- Ongoing investment in drug product capabilities, including pre-filled syringes
- Flexible infrastructure and advanced technologies that support stable, high-quality production across diverse modalities
Read More (Japanese)
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article